In patients who received previous sequential chemoradiotherapy , overall survival did not differ between the @ ( @ % ) patients in the tecemotide group and the @ ( @ % ) patients in the placebo group ( @ months -LSB- @ % CI @-@ @ -RSB- vs @ months -LSB- @-@ @ -RSB- , respectively ; adjusted HR @ , @-@ @ ; p = @ ) .